Search CommunityWalk:


Stealth Peptides

155 Gibbs Street, Suite 431
Rockville, MD, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Stealth Peptides is a biopharmaceutical company developing novel mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal, ophthalmologic, neurologic and metabolic conditions. The company was founded in 2006.

Stealth's has a rich and promising pipeline of preclinical and clinical compounds from a unique class of short peptides that target mitochondria. Its first clinical candidate, Bendavia(TM), targets the mitochondria to treat ischemia reperfusion injury.

Stealth's investor is Morningside Venture.